[Federal Register Volume 86, Number 60 (Wednesday, March 31, 2021)]
[Notices]
[Pages 16738-16739]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06644]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Re-Establishment of the Advisory Committee to the 
Director

    Pursuant to Section 222 of the Public Health Service Act (42 U.S.C. 
217a), as amended and the Federal Advisory Committee Act, as amended (5 
U.S.C. App), the Director, Centers for Disease Control and Prevention 
(CDC), announces the re-establishment of the Advisory Committee to the 
Director, Centers for Disease Control and Prevention.
    The Secretary, Department of Health and Human Services (HHS) and by 
delegation, the Director, CDC, are authorized under Sections 301 and 
311 of the Public Health Service Act, [42 U.S.C. Sections 241 and 243], 
as amended to: (1) Conduct, encourage, cooperate with, and assist other 
appropriate public authorities, scientific

[[Page 16739]]

institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in the prevention of infectious diseases and 
other preventable conditions, and in the promotion of health and well-
being; and (3) train State and local personnel in health work. The ACD, 
CDC, shall advise the Secretary, HHS, and the Director, CDC, on policy 
and broad strategies that will enable CDC to fulfill its mission of 
protecting health through health promotion, prevention, and 
preparedness.
    For information, contact Tiffany J. Brown, JD, MPH, Acting Deputy 
Chief of Staff, Office of the Director, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, Mail Stop H21-10, Atlanta, GA 30329-
4027, telephone (404) 498-6655; [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-06644 Filed 3-30-21; 8:45 am]
BILLING CODE 4163-18-P